Literature DB >> 1779131

[Morphological changes in the human cerebral cortex in dementia].

H Braak1, E Braak.   

Abstract

Many diseases of the brain leading to impairment of intellectual capacities are associated with morphological changes in the anteromedial portions of the temporal lobe. Among these are Alzheimer's disease, Parkinson's disease and the syndrome of dementia with argyrophilic grains. The hallmarks of Alzheimer's disease are intraneuronal neurofibrillary changes and extracellular amyloid deposits. The neurofibrillary changes consist of neurofibrillary tangles, neuritic plaques and neuropil threads. The distribution pattern of neurofibrillary changes differs from the distribution of amyloid deposits. The neurofibrillary changes exhibit a distinct but varying distribution pattern in different areas of the cerebral cortex. In fully developed Alzheimer's disease, both the hippocampal formation and isocortical association areas are severely involved while the brunt of the pathology is found in the entorhinal region. The entorhinal region receives information from various isocortical association areas and limbic circuits and projects to the hippocampal formation via the perforant path. This fibre tract is mainly generated by projection neurons within the superficial entorhinal cell layer. In Alzheimer's disease virtually all projection neurons within this layer are destroyed by neurofibrillary tangles. In cases of Parkinson's disease with progressive cognitive decline the neurofibrillary changes are confined to the outer cellular layer of the entorhinal region. In cases of "dementia with argyrophilic grains" the argyrophilic grains are predominantly encountered in the hippocampal formation and in the outer layers of the entorhinal region.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1779131

Source DB:  PubMed          Journal:  J Hirnforsch        ISSN: 0021-8359


  8 in total

1.  A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.

Authors:  Mario R Cornejo-Olivas; Luis Torres; Ignacio F Mata; Pilar Mazzetti; Diana Rivas; Carlos Cosentino; Miguel Inca-Martinez; Juan M Cuba; Cyrus P Zabetian; James B Leverenz
Journal:  Parkinsonism Relat Disord       Date:  2015-01-15       Impact factor: 4.891

2.  Classification of MRI and psychological testing data based on support vector machine.

Authors:  Wenlu Yang; Xinyun Chen; David S Cohen; Eric R Rosin; Arthur W Toga; Paul M Thompson; Xudong Huang
Journal:  Int J Clin Exp Med       Date:  2017-12

3.  Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context.

Authors:  Vicente Sancenon; Sue-Ann Lee; Christina Patrick; Janice Griffith; Amy Paulino; Tiago F Outeiro; Fulvio Reggiori; Eliezer Masliah; Paul J Muchowski
Journal:  Hum Mol Genet       Date:  2012-02-21       Impact factor: 6.150

Review 4.  The role of amyloidogenic protein oligomerization in neurodegenerative disease.

Authors:  Gregor P Lotz; Justin Legleiter
Journal:  J Mol Med (Berl)       Date:  2013-03-27       Impact factor: 4.599

Review 5.  Mechanisms of neuronal death in disease: defining the models and the players.

Authors:  Elena M Ribe; Esther Serrano-Saiz; Nsikan Akpan; Carol M Troy
Journal:  Biochem J       Date:  2008-10-15       Impact factor: 3.766

Review 6.  Regulation of caspases in the nervous system implications for functions in health and disease.

Authors:  Carol M Troy; Nsikan Akpan; Ying Y Jean
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 4.025

Review 7.  Advances in high-field magnetic resonance spectroscopy in Alzheimer's disease.

Authors:  Ningnannan Zhang; Xiaowei Song; Robert Bartha; Steven Beyea; Ryan D'Arcy; Yunting Zhang; Kenneth Rockwood
Journal:  Curr Alzheimer Res       Date:  2014-05       Impact factor: 3.498

8.  Selective Regional Loss of Cortical Synapses Lacking Presynaptic Mitochondria in the 5xFAD Mouse Model.

Authors:  Na-Young Seo; Gyu Hyun Kim; Jeong Eun Noh; Ji Won Shin; Chan Hee Lee; Kea Joo Lee
Journal:  Front Neuroanat       Date:  2021-06-25       Impact factor: 3.856

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.